Drug Detail:Climara pro (Estradiol and levonorgestrel (transdermal) [ ess-tra-dy-ol-and-lee-vo-nor-jess-trell ])
Generic Name: ESTRADIOL 0.045mg in 1d, LEVONORGESTREL 0.015mg in 1d
Dosage Form: patch
Drug Class: Sex hormone combinations
Drug Detail:Climara pro (Estradiol and levonorgestrel (transdermal) [ ess-tra-dy-ol-and-lee-vo-nor-jess-trell ])
Generic Name: ESTRADIOL 0.045mg in 1d, LEVONORGESTREL 0.015mg in 1d
Dosage Form: patch
Drug Class: Sex hormone combinations
Use estrogen-alone, or in combination with a progestogen, at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual women. Reevaluate postmenopausal women periodically as clinically appropriate to determine if treatment is still necessary.
One Climara Pro transdermal system is available for use.
Start therapy with Climara Pro 0.045 mg per day/0.015 mg per day applied to the skin once weekly. Start therapy at the lowest effective dose and the shortest duration consistent with the treatment goals. Attempts to discontinue Climara Pro should be made at 3 to 6 month intervals.
Apply Climara Pro 0.045 mg per day/0.015 mg per day applied to the skin once weekly.
Women not currently using continuous estrogen-alone therapy or estrogen plus progestogen therapy may start therapy with Climara Pro at any time. However, women currently using continuous estrogen-alone therapy or estrogen plus progestogen therapy should complete the current cycle of therapy before initiating Climara Pro therapy. Women often experience withdrawal bleeding at the completion of the cycle. The first day of this bleeding would be an appropriate time to begin Climara Pro therapy.